TGFB1 and systemic sclerosis: In SSc-ILD, activation of the innate and adaptive immune systems is hypothesized to result in endothelial and epithelial cell injury resulting in vasculopathy, aberrant transforming growth factor-beta (TGF-β) signaling, and the transformation to and expansion of myofibroblasts (10–12).